Maria Immacolata La Rotonda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Immacolata La Rotonda has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Fabiana Quaglia
Department of Pharmacy, University of Napoli Federico II, I-80131 Napoli, Italy
4 shared publications - Agnese Miro
Department of Pharmacy, University of Naples Federico II, Via D. Montesano 49, 80131 Napoli, Italy
2 shared publications - Francesca Ungaro
Department of Pharmacy, University of Naples Federico II, Naples, Italy
2 shared publications Brunella Cappello
Dipartimento di Chimica Farmaceutica e Tossicologica, Facoltà di Farmacia, Università degli Studi di Napoli ‘Federico II’-Via Domenico Montesano 49, 80131 Naples, Italy
1 shared publicationDaniela De Stefano
Dipartimento di Farmacologia Sperimentale, Università degli Studi di Napoli Federico II, Via Montesano 49, 80131 Naples, Italy
1 shared publication- Elias Fattal
Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France
1 shared publication
Latest Publications
- Open Access
Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties
Oligonucleotides (ONs) are synthetic fragments of nucleic acid designed to modulate the expression of target proteins. DNA-based ONs (antisense, antigene, aptamer or decoy) and more recently a new class of RNA-based ONs, the small interfering RNAs (siRNAs), have gained great attention for the treatment of different disease states, such as viral infections, inflammation, diabetes, and cancer. However, the development of therapeutic strategies based on ONs is hampered by their low bioavailability, poor intracellular uptake and rapid degradation in biological fluids. The use of a non-viral carrier can be a powerful tool to overcome these drawbacks. Lipid or polymer-based nanotechnologies can improve biological stability and cellular uptake of ONs, with possibility of tissue and/or cellular targeting. The use of polymeric devices can also produce a prolonged release of the ON, thus reducing the need of frequent administrations. This review summarizes advantages and issues related to the main non-viral vectors used for ON delivery.
Open AccessNano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties
Oligonucleotides (ONs) are synthetic fragments of nucleic acid designed to modulate the expression of target proteins. DNA-based ONs (antisense, antigene, aptamer or decoy) and more recently a new class of RNA-based ONs, the small interfering RNAs (siRNAs), have gained great attention for the treatment of different disease states, such as viral infections, inflammation, diabetes, and cancer. However, the development of therapeutic strategies based on ONs is hampered by their low bioavailability, poor intracellular uptake and rapid degradation in biological fluids. The use of a non-viral carrier can be a powerful tool to overcome these drawbacks. Lipid or polymer-based nanotechnologies can improve biological stability and cellular uptake of ONs, with possibility of tissue and/or cellular targeting. The use of polymeric devices can also produce a prolonged release of the ON, thus reducing the need of frequent administrations. This review summarizes advantages and issues related to the main non-viral vectors used for ON delivery.
- 8 February 2005
- Published by Wiley in The Journal of Gene Medicine
- Vol. 7 (6) , 771-781
Enhanced intracellular uptake and inhibition of NF‐κB activation by decoy oligonucleotide released from PLGA microspheres
Background: Nuclear factor‐κB (NF‐κB) transcription factor regulates the expression of genes involved in immune response and inflammation. NF‐κB activity can be efficiently inhibited by double‐stranded oligodeoxynucleotides (ODNs). In the present study, we investigated the potential of poly(DL‐lactic‐co‐glycolic acid) (PLGA) microspheres as delivery system for an ODN against NF‐κB in RAW 264.7 macrophages stimulated with lipopolysaccharide (LPS).Methods: Microspheres encapsulating ODN were prepared by the multiple emulsion/solvent evaporation technique and characterised in terms of size, morphology, encapsulation efficiency and in vitro release profile. In vitro uptake after 4 h and activity of ODN released from microspheres were evaluated in RAW 264.7 macrophages stimulated with LPS for 24, 48 and 72 h.Results: We prepared microspheres with a high encapsulation efficiency showing a very slow and almost constant in vitro release of ODN for up to 1 month. ODN slowly released from microspheres translocated better into LPS‐stimulated cells as compared with naked ODN. Incubation of cells with ODN‐encapsulating microspheres resulted in a decrease of tumor necrosis factor‐alpha (TNF‐α) and nitrite production, inducible nitric oxide synthase (iNOS) protein expression, as well as NF‐κB/DNA‐binding activity. Similar results were obtained with naked ODN only at about 80 times higher concentrations.Conclusions: Our results suggest that PLGA microspheres could be a useful tool to improve pharmacokinetics of a ODN decoy to NF‐κB and may represent a promising strategy to effectively inhibit the transcriptional activity of NF‐κB in inflammatory process. Copyright © 2005 John Wiley & Sons, Ltd.
- 8 February 2005
- Published by Wiley in The Journal of Gene Medicine
- Vol. 7 (6) , 771-781
Enhanced intracellular uptake and inhibition of NF‐κB activation by decoy oligonucleotide released from PLGA microspheres
Background: Nuclear factor‐κB (NF‐κB) transcription factor regulates the expression of genes involved in immune response and inflammation. NF‐κB activity can be efficiently inhibited by double‐stranded oligodeoxynucleotides (ODNs). In the present study, we investigated the potential of poly(DL‐lactic‐co‐glycolic acid) (PLGA) microspheres as delivery system for an ODN against NF‐κB in RAW 264.7 macrophages stimulated with lipopolysaccharide (LPS).Methods: Microspheres encapsulating ODN were prepared by the multiple emulsion/solvent evaporation technique and characterised in terms of size, morphology, encapsulation efficiency and in vitro release profile. In vitro uptake after 4 h and activity of ODN released from microspheres were evaluated in RAW 264.7 macrophages stimulated with LPS for 24, 48 and 72 h.Results: We prepared microspheres with a high encapsulation efficiency showing a very slow and almost constant in vitro release of ODN for up to 1 month. ODN slowly released from microspheres translocated better into LPS‐stimulated cells as compared with naked ODN. Incubation of cells with ODN‐encapsulating microspheres resulted in a decrease of tumor necrosis factor‐alpha (TNF‐α) and nitrite production, inducible nitric oxide synthase (iNOS) protein expression, as well as NF‐κB/DNA‐binding activity. Similar results were obtained with naked ODN only at about 80 times higher concentrations.Conclusions: Our results suggest that PLGA microspheres could be a useful tool to improve pharmacokinetics of a ODN decoy to NF‐κB and may represent a promising strategy to effectively inhibit the transcriptional activity of NF‐κB in inflammatory process. Copyright © 2005 John Wiley & Sons, Ltd.
- 1 January 2005
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 15 (2) , 137-143
Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: potential of spray-drying technique
- 1 January 2005
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 15 (2) , 137-143
Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: potential of spray-drying technique
- 1 September 2004
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 23 (1) , 57-64
Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations
- 1 September 2004
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 23 (1) , 57-64
Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations
- 1 November 1998
- Published by Elsevier in Il Farmaco
- Vol. 53 (10-11) , 655-661
Chromatographic indexes on immobilized artificial membranes for the prediction of transdermal transport of drugs
- 1 November 1998
- Published by Elsevier in Il Farmaco
- Vol. 53 (10-11) , 655-661
Chromatographic indexes on immobilized artificial membranes for the prediction of transdermal transport of drugs